| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/03/2006 | EP1104309B1 Co-lyophilized complex comprising a nucleic acid vector and a formulating agent |
| 05/03/2006 | EP0702717B1 Generation, concentration and efficient transfer of vsv-g pseudotyped retroviral vectors |
| 05/03/2006 | CN1768075A Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors |
| 05/03/2006 | CN1767815A Non-aqueous single phase vehicles and formulations utilizing such vehicles |
| 05/03/2006 | CN1766114A Plasmid containing recombinant immunological toxin MIP-1ª‡-DT390 aiming at activated Th1 cell, its preparation method and uses |
| 05/03/2006 | CN1254543C Method |
| 05/03/2006 | CN1254541C Novel compound |
| 05/03/2006 | CN1254272C Activation and inhibition of immune system |
| 05/03/2006 | CN1254234C Plasmid DNA (Lipogenes TM) and encapsulating therapeutica agent containing karyon-positioning signal /fusion-promoting peptide conjugate into targeted liposomes complex |
| 05/02/2006 | US7038035 Nucleic acids codes polypeptides; mutants; insertion a vector; culturing; recovering |
| 05/02/2006 | US7038028 Gene encoding promoter domain of tumor suppressor gene P51 and use thereof |
| 05/02/2006 | US7037903 Administering an adenovirus expression vector, expressing a protein on cancer cells for treating ovarian cancer, cervical cancer, stomach cancer and lung cancer |
| 05/02/2006 | US7037723 Highly infectious virus vector; forming expression cassettes; insertion into herpes virus genome; replication |
| 05/02/2006 | US7037718 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 05/02/2006 | US7037716 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 05/02/2006 | US7037712 DNA encoding ovine adenovirus (OAV287) and its use as a viral vector |
| 05/02/2006 | US7037709 Comprises nucleotide sequences coding microsomal enzymes for detoxification of xenobiotic compounds in liver; drug screening; gene therapy |
| 05/02/2006 | US7037685 Nucleotide sequence coding polypeptide for use in the treatment and prevent of viral diseases, infections and tumors |
| 05/02/2006 | US7037668 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
| 05/02/2006 | US7037665 Compositions comprising SNORF36 receptor compounds |
| 05/02/2006 | US7037652 Diagnosing prostate cancer in humans; obtain tissue sample, monitor gene expression, compare to control, evaluate for cancer |
| 05/02/2006 | US7037647 Prostate-specific membrane antigen and uses thereof |
| 05/02/2006 | US7037506 Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry |
| 05/02/2006 | US7037498 Antibodies to insulin-like growth factor I receptor |
| 05/02/2006 | US7037493 Method of inducing neuronal production in the brain and spinal cord |
| 05/02/2006 | US7037492 Gene transfer for studying and treating a connective tissue of a mammalian host |
| 05/02/2006 | US7037450 Production scale method of forming microparticles |
| 05/02/2006 | CA2184375C Oligonucleotide n3'-p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties |
| 04/27/2006 | WO2006044842A2 Pancreatic islet beta-cell-like macrophages and methods to produce them |
| 04/27/2006 | WO2006044486A2 Methods and compositions for the utilization and targeting of osteomimicry |
| 04/27/2006 | WO2006044334A2 Platelet-derived growth factor compositions and methods of use thereof |
| 04/27/2006 | WO2006043722A1 Chimeric (double) decoy |
| 04/27/2006 | WO2006043615A1 Use of immunesuppressant receptor |
| 04/27/2006 | WO2006043060A2 Mam domain containing protein |
| 04/27/2006 | WO2006043036A2 Treatment of diabetes |
| 04/27/2006 | WO2006042418A1 Antiviral oligonucleotides |
| 04/27/2006 | WO2006042396A1 Modulation of neuroglia-derived bdnf in the treatment and prevention of pain |
| 04/27/2006 | WO2006009919A3 Improved efficacy of immunotherapy by integrating diagnostic with therapeutic methods |
| 04/27/2006 | WO2005120570A3 Therapeutic targeting of parc/ccl18 and its signaling in pulmonary fibrosis |
| 04/27/2006 | WO2005118788A3 Novel artificial antigen presenting cells and uses therefor |
| 04/27/2006 | WO2005110491A3 Inducible dimerization of growth factor receptors for treating cancer |
| 04/27/2006 | WO2005105157A3 INHIBITION OF HAIRLESS PROTEIN mRNA |
| 04/27/2006 | WO2005094348A3 Anti-lfl2 antibodies for the diagnosis, prognosis and treatment of cancer |
| 04/27/2006 | WO2005092918A3 Targeting polypeptide |
| 04/27/2006 | WO2005087792A3 Materials and methods relating to the treatment of glioblastomas |
| 04/27/2006 | WO2005086825A3 Methods and compositions for treatment of diseases associated with aberrant microsatellite expansion |
| 04/27/2006 | WO2005080581A3 Insulated herpesvirus-derived gene expression cassettes for sustained and regulatable gene expression |
| 04/27/2006 | WO2005079815A3 Methods and reagents for treating autosomal dominant diseases of the eye |
| 04/27/2006 | WO2005072241A3 Inhibition of bright function as a treatment for excessive immunoglobulin production |
| 04/27/2006 | WO2004026453A3 Microcapsules and methods of use |
| 04/27/2006 | WO2003040333A3 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 04/27/2006 | US20060089674 Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 04/27/2006 | US20060089493 Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas |
| 04/27/2006 | US20060089326 Immunostimulatory nucleic acid molecules |
| 04/27/2006 | US20060089325 Antisense modulation of PTP1B expression |
| 04/27/2006 | US20060089324 RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof |
| 04/27/2006 | US20060089323 RNA interference; respiratory syncytial virus (RSV), parainfluenza virus (PIV) |
| 04/27/2006 | US20060089322 Antisense oligonucleotides for identifying drug targets and enhancing cancer therapies |
| 04/27/2006 | US20060089321 Cks1 inhibitors |
| 04/27/2006 | US20060089320 Modulation of type IIß phosphoinositide phosphate kinase |
| 04/27/2006 | US20060089306 New epilepsy mutations |
| 04/27/2006 | US20060089303 Cancer-testis antigens |
| 04/27/2006 | US20060088938 Methods and compositions for use in spliceosome mediated RNA trans-splicing in plants |
| 04/27/2006 | US20060088932 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents |
| 04/27/2006 | US20060088913 Mutation associated with epilepsy |
| 04/27/2006 | US20060088907 Novel 13237, 18480, 2245, 16228, 7677, 26320, 46619, 33166, 16836, 46867, 21617, 55562, 39228, 62088, 46745, 23155, 21657, 42755, 32229, 22325, 46863 and 32252 molecules and uses therefor |
| 04/27/2006 | US20060088881 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 molecules |
| 04/27/2006 | US20060088880 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 04/27/2006 | US20060088864 Aptamer regulated nucleic acids and uses thereof |
| 04/27/2006 | US20060088846 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 04/27/2006 | US20060088837 Expression system for stem-loop rna molecule having rnai effect |
| 04/27/2006 | US20060088835 Schizophrenia associated genes |
| 04/27/2006 | US20060088824 Used in assays to identify PAP-1/WIP-1 interaction inhibitors; West Nile virus (WNV) |
| 04/27/2006 | US20060088820 Detecting superantigen activity in a biological sample |
| 04/27/2006 | US20060088599 Amino functionalized ORMOSIL nanoparticles as delivery vehicles |
| 04/27/2006 | US20060088551 Functional fragments of HIV-1 VPR protein and methods of using the same |
| 04/27/2006 | US20060088546 Antigens for raising an immune response against rickettsieae and ehrlichieae pathogens |
| 04/27/2006 | US20060088542 Imidazoquinoline adjuvants for vaccines |
| 04/27/2006 | US20060088537 Protein involved in cancer |
| 04/27/2006 | US20060088536 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles |
| 04/27/2006 | US20060088535 Method for enhancing long-term memory in a subject and uses thereof |
| 04/27/2006 | US20060088532 Lymphatic and blood endothelial cell genes |
| 04/27/2006 | US20060088512 Treatment of T cell disorders |
| 04/27/2006 | US20060088511 Cancer therapy sensitizer |
| 04/27/2006 | US20060088508 Method for obtaining characterized muscle-derived cell populations and uses |
| 04/27/2006 | US20060088504 Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein Al, very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol |
| 04/27/2006 | US20060087736 Amyloid peptide inactivating enzyme to treat alzheimer's disease |
| 04/27/2006 | CA2584459A1 Modulation of neuroglia-derived bdnf in the treatment and prevention of pain |
| 04/27/2006 | CA2584207A1 Antiviral oligonucleotides |
| 04/27/2006 | CA2583860A1 Vehicle for the transport of a chosen molecule to a cell |
| 04/27/2006 | CA2583576A1 Chimera (double) decoy |
| 04/26/2006 | EP1650312A2 Functional assay of high-density lipoprotein |
| 04/26/2006 | EP1650309A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/26/2006 | EP1650221A2 Novel compounds |
| 04/26/2006 | EP1649859A1 Pharmaceutical compositions comprising at least one poorly diffusible anticancer drug and a olidodeoxynucleotide immunestimulant |
| 04/26/2006 | EP1649028A2 Adenoviral vector-based vaccines |
| 04/26/2006 | EP1649019A2 Improved inhibitor nucleic acids |
| 04/26/2006 | EP1649018A2 Sp1 and sp3 targeted cancer therapies and therapeutics |
| 04/26/2006 | EP1648997A2 Methods of treatment and disgnosis using modulators of virus-induced cellular gene sequences |
| 04/26/2006 | EP1648931A2 Novel multifunctional cytokines |